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The adult pancreas is capable of limited regenera-
tion after injury but has no defined stem cell popu-
lation. The cell types and molecular signals that
govern the production of new pancreatic tissue
are not well understood. Here, we show that inacti-
vation of the SCF-type E3 ubiquitin ligase substrate
recognition component Fbw7 induces pancreatic
ductal cells to reprogram into a, d, and b cells.
Loss of Fbw7 stabilized the transcription factor
Ngn3, a key regulator of endocrine cell differentia-
tion. The induced b cells resemble islet b cells in
morphology and histology, express genes essential
for b cell function, and release insulin after glucose
challenge. Thus, loss of Fbw7 appears to reawaken
an endocrine developmental differentiation program
in adult pancreatic ductal cells. Our study high-
lights the plasticity of seemingly differentiated adult
cells, identifies Fbw7 as a master regulator of cell
fate decisions in the pancreas, and reveals adult
pancreatic duct cells as a latent multipotent cell
type.
INTRODUCTION
The pancreas comprises an exocrine component (ductal and
acinar cells) and an endocrine component (b cells, a cells,
d cells, pancreatic polypeptide-positive [pp] cells, and ε cells).
The endocrine cells are organized in defined islet structures
embedded in the acinar compartment, which function as key
regulators of carbohydrate metabolism (Edlund, 2002). The
autoimmune disease Type 1 diabetes irreversibly destroys insu-
lin-secreting b cells in pancreatic islets, resulting in a lack of
insulin production and hyperglycemia (Atkinson et al., 2011).
Treatment is most commonly with insulin injections, but the de-
gree of glycemic control with this approach does not compare to
functional pancreatic b cells. Regenerative b cell treatments in
diabetic patients could allow for the long-term restoration of
normal glycemic control and thus represent a potentially curative
therapy (Yi et al., 2013).CThe generation of new pancreatic b cells is being pursued on
several fronts in vitro, including differentiation of induced plurip-
otent stem cells (iPSCs) and reprogramming of other pancreatic
cell types (Pagliuca and Melton, 2013). Regenerating pancreatic
b cells in situ is an attractive alternative to these approaches,
driven by evidence of spontaneous b cell neogenesis in the adult
pancreas (Bonner-Weir et al., 2004; Dor et al., 2004; Lysy et al.,
2012; Pagliuca and Melton, 2013; Teta et al., 2005). b cell regen-
eration during adulthood is very limited but can be achieved
experimentally using pancreatic duct ligation in mice (Xu et al.,
2008) and pancreatectomy in rats (Bonner-Weir et al., 2004).
Inducible depletion of acinar and islet cells with diphtheria toxin
showed that duct cells can give rise to both acinar and endocrine
cells (Criscimanna et al., 2011). Thus, ductal cells in the adult
pancreas show a latent propensity for b cell generation. Addi-
tionally, genetic approaches have converted other pancreatic
cell types into b cells. Adenoviral overexpression of the three
transcription factors neurogenin-3 (Ngn3), Maf1a, and Pdx1 is
sufficient to convert adult acinar cells into b cells (Zhou et al.,
2008), and overexpression of Pax4 converts glucagon-produc-
ing a cells into b cells (Collombat et al., 2009). However, the ca-
pacity for b cell neogenesis in the normal adult pancreas, and the
regulatory events surrounding it, remain largely unknown.
Ngn3 is the earliest factor that specifically regulates the
development of the endocrine compartment in the embryonic
pancreas (Habener et al., 2005). Ngn3/ mice completely lack
endocrine islet development (Gradwohl et al., 2000), and trans-
genic overexpression of Ngn3 activates an islet differentiation
program in the embryo and in cultured pancreatic ductal cell
lines (Heremans et al., 2002; Schwitzgebel et al., 2000). In the
adult pancreas, Ngn3 expression is very limited, but levels rise
during b cell neogenesis induced by pancreatic duct ligation,
where Ngn3 is required for b cell replenishment (Van de Casteele
et al., 2013; Xu et al., 2008). Moreover, expansion of Ngn3+ cells
bordering the ducts contributes to the b cell expansion observed
when overexpressing Pax4 (Al-Hasani et al., 2013), indicating
thatmanipulation of Ngn3 levels and/or activitymay be beneficial
for regeneration therapies. Ngn3 is a highly unstable protein
(Roark et al., 2012), and the level and timing of its expression
must be precisely controlled to ensure the correct production
of b cells, but the details of its posttranslational regulation remain
elusive.
Fbw7 (F-box and WD-40 domain protein 7) is the substrate
recognition component of an evolutionarily conserved SCFell Stem Cell 15, 139–153, August 7, 2014 ª2014 The Authors 139
Figure 1. Pdx1-Driven Deletion of Fbw7 in
the Pancreas Induces Occurrence of Cells
in the Ducts Displaying b Cell Hallmarks
(A–D) Hematoxylin and eosin (H&E) staining of
Fbw7f/f or Pdx1-Cre; Fbw7f/f pancreas. (a) Fbw7f/f
pancreatic islet; (b) Fbw7f/f duct; (c) and (d) Pdx1-
Cre; Fbw7f/f cells with altered morphology in the
ducts.
(E and F) Double IF for insulin (ins) and cytokeratin
19 (CK19) in Fbw7f/f (E) or Pdx1-Cre; Fbw7f/f (F)
pancreas at 4 weeks.
(G–I) Double IF for Glut2 and insulin in Fbw7f/f (G)
or Pdx1-Cre; Fbw7f/f (H and I) pancreas at
4 weeks. Nuclei were counterstained with DAPI.
White dashed squares in (F) and (H) represent the
areas magnified in (F) and (I) respectively. n > 5
mice per genotype (representative picture shown).
See also Figure S1.
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ligase. SCF(Fbw7) degrades proteins that function in cellular
growth and division pathways, including c-Myc, cyclin E,
Notch, and c-Jun (Welcker and Clurman, 2008). Emerging evi-
dence shows that Fbw7 controls stem cell self-renewal, cell
fate decisions, survival, and multipotency in numerous tissues,
including the hematopoietic (Iriuchishima et al., 2011) and ner-
vous systems (Hoeck et al., 2010; Matsumoto et al., 2011), liver
(Onoyama et al., 2011), and intestine (Sancho et al., 2010). This140 Cell Stem Cell 15, 139–153, August 7, 2014 ª2014 The Authorssuggests that Fbw7 has a crucial func-
tion in fundamental cell differentiation
processes.
Here, we show that Fbw7 contributes
to the regulation of Ngn3 stability, and
loss of Fbw7 induces a direct ductal-to-
b cell differentiation in the adult pancreas.
Our study not only reveals a role for Fbw7
in pancreatic cell fate determination and
identifies Ngn3 as a target of Fbw7 but
also demonstrates that ductal cells can
be induced to alter their identity in the
adult pancreas in the absence of injury
to the organ with a single genetic change.
RESULTS
Fbw7 Deletion in the Pancreas
Induces Scattered Duct Cells to
Display Functional Mature b Cell
Hallmarks
Given the role of Fbw7 in controlling cell
fate decisions in other organs, we asked
whether Fbw7 also functions in cell type
specification in the pancreas. We deleted
Fbw7 in embryonic pancreatic progenitor
cells using a Cre recombinase under the
control of the Pdx1 promoter (Pdx1-Cre;
Fbw7f/f mice). Although pancreatic organ
size and gross morphology appeared
normal, histological analysis revealedincreased ductal cell proliferation and an expansion of the ductal
compartment (Figures S1A and S1B available online), consistent
with the increase in proliferation upon Fbw7 deletion observed in
other organs (Hoeck et al., 2010; Matsumoto et al., 2011;
Onoyama et al., 2007, 2011; Sancho et al., 2010). Unexpectedly,
scattered cells in the Pdx1-Cre; Fbw7f/f ducts showed an
enlarged cytoplasm and smaller rounded nuclei when compared
with surrounding ductal cells, andmore closely resembled islet b
cells (Figures 1A–1D). Insulin expression, which is normally
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these aberrant ductal cells (Figure 1F). The majority of insulin-
positive cells in Pdx1-Cre; Fbw7f/f ducts were devoid of the
ductal cell marker cytokeratin-19 (CK19), but costaining of
CK19 and insulin was sometimes observed (Figure 1F), suggest-
ing an intermediate transition state between ductal and insulin-
positive cells. No insulin costaining with the acinar cell marker
amylase was observed (Figures S1C and S1D). Thus, the
absence of Fbw7 appears to trigger abnormal differentiation of
a subset of ductal cells, biasing them toward an endocrine fate.
In addition to ectopic insulin-positive cells (in 17% of ducts),
Pdx1-Cre; Fbw7f/f ducts also contained cells expressing the
a cell marker glucagon, albeit less frequently (3% of ducts)
(Figures S1E and S1F). We also observed glucagon/insulin
double-positive cells in Pdx1-Cre; Fbw7f/f ducts (Figures S1G–
S1I), similar to progenitor cells described in human embryonic
pancreas (Piper et al., 2004). Thus, deletion of Fbw7 in the
pancreas promotes the occurrence of cells coexpressing
markers of different pancreatic cell lineages, a cellular pheno-
type that is not normally observed in the adult pancreas.
One of the features of functional b cells is the expression of the
glucose transporter Glut2 (Slc2a2). In control animals, Glut2 was
coexpressed with insulin in islet b cells by double insulin/glut2
immunofluorescence (IF) (Figure 1G). Glut2 was also coex-
pressed with insulin in the Pdx1-Cre; Fbw7f/f aberrant ductal
cells (Figures 1H and 1I).
Inducible Deletion of Fbw7 in the Adult Pancreas
Promotes b Cell Neogenesis
Because Pdx1-expressing progenitors give rise to all the pancre-
atic lineages (Oliver-Krasinski and Stoffers, 2008), the emer-
gence of insulin-positive cells in Pdx1-Cre; Fbw7f/f ducts could
be due to a developmental defect. To test whether Fbw7 deletion
can induce b cell neogenesis in adult mice, and to clarify the cells
that give rise to ectopic b cells, we combined inducible Fbw7
deletion using the R26-CreERT line with lineage tracing using
R26-LSL-YFP. ‘‘RY’’ control mice express a tamoxifen-inducible
form of Cre recombinase from the ubiquitous Rosa26 (R26)
promoter, leading to the permanent expression of yellow fluores-
cent protein (YFP) in recombined cells. In the Fbw7f/f back-
ground (‘‘RFY’’ line, Figure 2A), tamoxifen treatment results in
recombination of the floxed Fbw7 alleles in Cre-expressing cells
concomitantly with activation of YFP expression (Figure 2B).
Intraperitoneal injection of tamoxifen induced recombination
in all pancreatic cell types but with different efficiencies. Almost
all acinar cells showed YFP positivity (91%), while recombination
occurred much less frequently in islet (10%) and ductal cells
(5%) (Figures 2C and 2D). Despite the high percentage of recom-
bination in the acinar compartment (Figure 2D), no insulin positiv-
ity was observed in cells with acinar cell morphology, and insulin/
amylase double-positive cells could not be detected in the RFY
pancreas (Figures 2E–2N). Likewise, direct intrapancreatic injec-
tion of 4-OH-tamoxifen into the pancreatic tail resulted in exclu-
sive recombination in acinar cells, and here, no b cell neogenesis
was observed (Figures S2A–S2D). In contrast, despite the low
percentage of recombination in ducts (5%), RFY mice gave
rise to insulin/green fluorescent protein (GFP) double-positive
cells in ducts as early as 13 days postintraperitoneal injection
of tamoxifen (Figures 2E–2N) as well as at later time pointsC(Figures S2E and S2F). Therefore, Fbw7 deletion in ductal cells,
but not in acinar cells, induces the acquisition of b cell identity.
Deletion of Fbw7 in the Pancreas Leads to Increased
Ngn3 Protein Levels
Fbw7 targets many proteins involved in proliferation and differ-
entiation for proteasomal degradation, such as N-terminally
phosphorylated c-Jun (p-c-JunSer73), Notch intracellular domain
1 (NICD1), phosphorylated c-Myc, and phosphorylated Cyclin
E (Welcker and Clurman, 2008). It has been shown that
SCF(Fbw7)-mediated substrate degradation is tissue specific
(Hoeck et al., 2010; Ishikawa et al., 2008; Nakayama and Na-
kayama, 2006; Onoyama et al., 2007, 2011; Sancho et al.,
2010; Thompson et al., 2008; Wang et al., 2012). Western blot-
ting of lysates from whole Pdx1-Cre; Fbw7f/f pancreas, in
which Fbw7 is inactivated in all pancreatic cell types, showed
increased p-c-JunSer73 and NICD1 protein levels when
compared to Fbw7f/f controls, while phosphorylated c-Myc
and Cyclin E levels were not substantially affected (Figure 3A;
quantifications in Figures S3A and S3B). In b cells, NICD1 and
p-c-JunSer73 were barely detectable, either in control RY or in
Fbw7-deleted RFY pancreas (Figure S3C). In the acinar
compartment, the loss of Fbw7 did not increase p-c-JunSer73
or NICD1 in RFY compared with RY mice (Figure S3D). In order
to analyze Fbw7 function in ducts, we examined sections from
Pdx1-Cre; Fbw7f/f animals. p-c-JunSer73 fluorescence intensity
was increased in Pdx1-Cre; Fbw7f/f compared with control ducts
(Figures 3B and 3C), suggesting that SCF(Fbw7) primarily acts in
pancreatic ductal cells.
Of the known substrates increased by Fbw7 loss in the
pancreas, none are thought to be involved in b cell neogenesis.
While Notch has been reported to be involved in embryonic
pancreatic differentiation, it has been proposed to inhibit b cell
neogenesis rather than promoting it (Esni et al., 2004; Murtaugh
et al., 2003). We therefore examined the possibility that Fbw7
in the pancreas may control the levels of one or more other
substrates. Transcription factors involved in embryonic b cell
development include Pdx1, Ngn3, Hnf3, and Hnf6 (Zaret,
2008). Pdx1, Hnf3, and Hnf6 protein levels were unaltered in
Pdx1-Cre; Fbw7f/f compared with Fbw7f/f pancreas, but the
protein levels of Ngn3 were strongly increased (Figure 3D; quan-
tifications in Figures S3E and S3F). Ngn3 messenger RNA
(mRNA) levels were also increased (Figure 3E), in agreement
with previous reports of positive autoregulatory loops controlling
Ngn3 expression (Ejarque et al., 2013; Wang et al., 2008). The in-
crease in Ngn3 after Fbw7 loss also correlated with highermRNA
levels of the Ngn3 transcriptional target genes Insm1,HeyL,Ctgf,
and Nkx2-2 (Swales et al., 2012) when analyzed by quantitative
PCR (qPCR) (Figure 3E), and increased protein levels of the
Ngn3 transcriptional targets NeuroD1 and Insm1 (Figures 3D,
3F, 3G, S3E, and S3F). Ngn3 is a key regulator of endocrine dif-
ferentiation, making it an excellent candidate for inducing b cell
neogenesis induced by Fbw7 loss.
Fbw7 Binds to, Ubiquitinates, and Induces Proteasomal
Degradation of Ngn3
To investigate the mechanism by which Fbw7 affects Ngn3, we
first analyzed the stability of Ngn3 protein using cycloheximide to
inhibit protein synthesis. Ngn3 half-life was increased more thanell Stem Cell 15, 139–153, August 7, 2014 ª2014 The Authors 141
Figure 2. Inducible Deletion of Fbw7 in the Adult Pancreas Promotes b Cell Neogenesis
(A) Scheme of the RY (R26-CreERT; R26-LSL-YFP) and RFY (R26-CreERT; Fbw7f/f; R26-LSL-YFP) mouse models.
(B) Schematic diagram of RY pancreas before and after tamoxifen (Tam) injection.
(C) GFP immunoperoxidase staining in RY pancreas after tamoxifen injection. Section shows acinar cells, an islet, and a duct. n > 3 mice per genotype.
(D) Quantification of GFP-positive cells in the different pancreatic cell type compartments ofRY (n = 3) mice 13 days postinjection. A, acinar; I, islet; D, ducts. Data
are represented as mean + SEM.
(E–N) Triple IF for insulin (ins), GFP, and amylase (amy) in RFYmice 13 days after tamoxifen injection. n > 3 mice per genotype. Nuclei were counterstained with
DAPI. Ducts are circled with a yellow dashed line. White dashed squares represent the area magnified in the squares shown below.
See also Figure S2.
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bilize Ngn3 protein (Figure 4A). Ngn3-hemagglutinin (Ngn3-HA)
coimmunoprecipitated Flag-tagged Fbw7 isoform-a and, to a
lesser extent, isoform-b (Figure 4B, left panel; and vice versa,
as shown in the right panel), and endogenous Fbw7 interacted
with Ngn3-HA (Figure 4C). Ngn3 is a heavily ubiquitinated protein
(Roark et al., 2012), but Ngn3 ubiquitination was strongly
reduced in Fbw7D HCT116 cells when compared to congenic
Fbw7wt cells (Figure 4D). In vitro, wild-type (WT) Fbw7–Flag
protein complexes promoted efficient ubiquitination of recombi-
nant Ngn3, but the inactive mutant Fbw7a-DFbox–Flag did not142 Cell Stem Cell 15, 139–153, August 7, 2014 ª2014 The Authors(Welcker et al., 2004) (Figures 4E and S4A). All together, these
data suggest that Ngn3 is a substrate of the SCF(Fbw7) ubiquitin
ligase.
Most Fbw7 substrates contain a phosphodegron motif that
serves as the recognition motif for Fbw7 interaction (Welcker
and Clurman, 2008). Multiple higher molecular weight bands of
Ngn3-HA detected by immunoblot collapsed after calf intestinal
phosphatase (CIP) treatment, suggesting that they represent
phosphorylated forms. Silencing of Fbw7 increased the levels
of these higher molecular weight forms (Figure 4F). GSK3b is
the kinase responsible for modifying the phosphodegron motifs
Figure 3. Fbw7 Loss in the Pancreas Leads to Increased Ngn3 Protein Levels
(A–D) In (A) and (D), a western blot analysis is shown of Fbw7f/f and Pdx1-Cre; Fbw7f/fwhole pancreas lysates. n = 3mice per genotype. (B) Double IF of CK19 and
p-c-JunSer73 in Fbw7f/f andPdx1-Cre; Fbw7f/f pancreas at 4 weeks. n > 3mice per genotype (representative picture shown). (C) Quantification of experiment in (B).
p-c-Jun fluorescence intensity wasmeasured using LSM software; each dot represents the mean intensity of a single cell. Fbw7f/f n = 471 cells (20 ducts/2 mice);
Pdx1-Cre; Fbw7f/f n = 505 cells (20 ducts/3 mice).
(E) qPCR analysis of Ngn3 target genes from Fbw7f/f and Pdx1-Cre; Fbw7f/f mouse pancreas at 4 weeks. n > 3 mice per genotype. Error bars indicate SEM.
(F) IF for Insm1 in Fbw7f/f and Pdx1-Cre; Fbw7f/f pancreas at 4 weeks. Ducts are circled with a yellow dashed line.
(G) Quantification of experiment in (F). Insm1 fluorescence intensity per cell was measured as for p-c-Jun above. Fbw7f/f n = 518 cells (20 ducts/2 mice);
Pdx1-Cre; Fbw7f/f n = 527 cells (20 ducts/3 mice).
Error bars in (C) and (G) represent mean ± SD. See also Figure S3 and Table S1.
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et al., 2004). In silico analysis revealed a GSK3b consensus
site at the Ngn3 C terminus (Ser183–Ser187). GSK3b inhibitor
treatment increased Ngn3 protein levels (Figure 4G), suggesting
that GSK3b regulates the stability of Ngn3. We generated con-
structs of Ngn3 with Ser183 and/or Ser187 mutated to alanine
to assess the role of the putative phosphodegron motif (Fig-
ure 4H). Mutation of the predicted GSK3b phosphorylation site
Ser183 altered the electrophoretic mobility of Ngn3 protein,
while mutation of Ser187 had less effect (Figure 4I, left panel).
While WT Ngn3 could efficiently interact with Fbw7, the interac-
tion was severely impaired when Ser183 was mutated (Ngn3-AA
and Ngn3-AS; Figure 4I, right panel). Accordingly, while the
mRNA levels from all four Ngn3 constructs were comparable,
the stability of Ngn3-AA and Ngn3-AS was greatly increased
(Figures S4B and S4J). These data suggest that Fbw7 directlyCcontrols Ngn3 stability by regulating its ubiquitination and pro-
teasomal degradation and that GSK3b-mediated phosphoryla-
tion of Ser183 might regulate this process. Since Ngn3 has
been shown to be involved in b cell neogenesis in the adult
pancreas (Al-Hasani et al., 2013; Baeyens et al., 2006; Xu
et al., 2008), accumulation of Ngn3 protein is likely to contribute
to adult b cell neogenesis induced by Fbw7 inactivation.
Conditional Overexpression of Ngn3-AA in the Adult
Pancreatic Ducts Induces b Cell Neogenesis
To determine whether accumulation of Ngn3 protein is sufficient
to induce b cell neogenesis, we generated a conditional induc-
ible transgenic mouse line that expresses the phospho mutant,
stable form of Ngn3 (Ngn3-AA) together with GFP after Cre
recombination (Pdx1-Cre; Rosa26-loxSTOPlox-Ngn3-AA-IRES-
GFP or Pdx1-Cre; R26-LSL-Ngn3-AA; Figure 5A). Pdx-Creell Stem Cell 15, 139–153, August 7, 2014 ª2014 The Authors 143
Figure 4. Fbw7 Binds to and Ubiquitinates Ngn3 and Induces Its Proteasomal Degradation
(A) Western blot analysis of Ngn3 protein levels during a cycloheximide (CHX) time course after silencing Fbw7. Graph shows mean Ngn3 levels normalized to
actin, as a percentage of initial protein levels. n = 3 independent experiments.
(B) Ngn3–HA and Fbw7a–Flag/Fbw7b–Flag IP from cotransfected HEK293T cells. Western blots (WB) of input and IP material are shown.
(C) HA IP from HCT116-Fbw7wt and Fbw7 knockout (Fbw7D) cells transfected with Ngn3-HA. Anti-Fbw7 (Bethyl Laboratories) detects endogenous Fbw7.
(D) In vivo Ngn3 ubiquitination is reduced in Fbw7D compared with Fbw7wt cells. Ubiquitinated Ngn3 was resolved by Ni2+-NTA affinity purification and
immunoblotting with anti-Ngn3 antibody.
(E) Recombinant Ngn3 (rNgn3-myc) is ubiquitinated in vitro, using Flag-IP complexes of pcDNA3, Fbw7a-Flag, or Fbw7a-DFbox-Flag from transfected HEK293T
cells. Ubiquitinated complexes were enriched by Ni2+-NTA affinity purification before immunoblotting.
(F) Calf intestinal phosphatase (CIP) treatment of lysates from Ngn3-HA and sh-control/sh-Fbw7 cotransfected HEK293T cells.
(legend continued on next page)
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Fbw7 Loss Reprograms Ductal Cells to b Cellsinduced recombination in mouse pancreas but not in liver or tail
(Figure 5B). Ngn3 protein, which is undetectable in control adult
pancreas, was detected in Pdx1-Cre; R26-LSL-Ngn3-AA
pancreas (Figure 5C) but not in liver. Pdx1-Cre; R26-LSL-
Ngn3-AA pancreas showed increased Ngn3 and Ins2 mRNA
levels when compared to unrecombined R26-LSL-Ngn3-AA
mice (Figure 5D). Transgenic Ngn3-AA expression resulted in
increased b cell area as analyzed by immunostaining for insulin
(Figures 5E and 5F). These data suggested that the overexpres-
sion of a stable form of Ngn3 (Ngn3-AA) from embryonic
pancreas development onward results in an increase in b cells.
In order to test whether overexpression of Ngn3-AA in the adult
pancreatic ducts was sufficient to induce b cell reprogramming,
we crossed R26-LSL-Ngn3-AA mice to CK19-CreERT mice, in
which the expression of tamoxifen-inducible Cre-ERT protein
is driven by the promoter of the ductal marker cytokeratin 19
(Means et al., 2008) (Figure 5G). Thirteen days post-tamoxifen
injection (Figure 5H), GFP expression could be detected specif-
ically in ductal cells of CK19-CreERT; R26-LSL-Ngn3-AA mice,
while it was absent in R26-LSL-Ngn3-AA ducts (Figure 5I).
Furthermore, we detected a significant increase in insulin-posi-
tive ductal cells in tamoxifen-injected CK19-CreERT; R26-LSL-
Ngn3-AA pancreas (Figures 5J and 5K), suggesting that
Ngn3-AA overexpression in the adult pancreatic duct is sufficient
to induce ductal-to-b cell conversion.
Fbw7 Deletion in the Adult Pancreatic Ducts Induces
Direct Conversion of Ductal Cells into b Cells
The aforementioned data suggest that Fbw7 may control adult
b cell neogenesis by regulating Ngn3 protein stability. To test
whether b cells arise as a direct consequence of Fbw7 loss
in ductal cells, we asked whether loss of Fbw7, specifically in
the adult ductal compartment, is sufficient to achieve cell
conversion. To this end, we generated CK19-CreERT; Fbw7+/+;
R26-LSL-YFP (‘‘CY’’) control and CK19-CreERT; Fbw7f/f; R26-
LSL-YFP (‘‘CFY’’) inducible Fbw7 deletion mice (Figures 6A
and 6B). The efficiency of recombination 2 weeks after tamoxifen
injection was between 40% and 50% in both CY and CFY ducts,
as reported previously (Means et al., 2008). Complete recombi-
nation was confirmed by PCR analysis of genomic DNA isolated
from YFP+ CFY cells (Figure 6C). qPCR analysis demonstrated
that Fbw7 mRNA was highly expressed in CY ductal cells
but undetectable in CFY ductal cells and mature pancreatic
b-cells sorted from MIP-GFP mice (in which GFP expression is
driven by the insulin promoter) (Figure 6D). These data suggest
that Fbw7 mRNA is enriched in ductal cells, in agreement
with substrate stabilization predominantly in this cell type after
Fbw7 loss (Figure 3B).
Fbw7 inactivation in ductal cells did not alter the number of
ducts (Figure 6E) or islets (Figure 6F). However, a significant
number of insulin-positive cells (almost 0.5%, i.e. 1% of the(G) GSK3b inhibitor (SB216763) treatment of cells transfected with Ngn3-HA.
(H) Graphic scheme of Ngn3 mutant constructs generated, showing the putative
(I) Ser183Ala mutation (AA, AS) disrupts Ngn3 interaction with Fbw7. Left: input. R
indicated mutant construct.
(J) Ser183Ala mutation (AA, AS) increases Ngn3 stability. Ngn3 protein levels we
Ngn3–HA mutants. Graph shows mean Ngn3 levels normalized to actin, as a pe
In (B)–(I), n > 2 independent experiments. Error bars in (A) and (J) represent SEM
CFbw7 knockout cells if considering 50% recombination effi-
ciency) was observed in the ducts of CFYmice, while they rarely
arose in CY mice (Figure 6G). About 12% of the CFY ducts
contained induced b cells, typically between one and three cells
per duct. It is interesting that 3.8% of CFY ducts contained
glucagon-positive a cells and 5.5% contained somatostatin-
positive d cells, while pp or amylase-positive ductal cells were
never detected (Figures S4C and S4D). Thus, deletion of Fbw7
in adult pancreatic ductal cells induces conversion of some
ductal cells to a or d cells or, most frequently, to b cells.
Inactivation of Fbw7 could trigger resident ductal progenitor
cell proliferation followed by redifferentiation or induce direct
transdifferentiation. To distinguish between these possibilities,
Fbw7 inactivation and lineage tracing was combined with long-
termbromodeoxyuridine (BrdU) labeling. BrdUwas incorporated
in scattered cells in the pancreatic CY ducts and increased in
CFY ducts (Figures 6H, 6I, and S4E). However, less than 1% of
insulin-positive CFY duct cells were labeled after 2 weeks of
continuous BrdU exposure, beginning directly before Fbw7
deletion (Figures 6J, S4F, and S4G). Thus Fbw7 deletion in the
adult pancreatic ducts induces direct conversion of a subset of
exocrine ductal cells into endocrine b cells, without a require-
ment for cell proliferation.
Induced b Cells in Adult Fbw7 Mutant Ducts Resemble
Functional b Cells
To explore the functionality of the b cells formed after Fbw7 dele-
tion, we performed mRNA expression profiling of GFP+ sorted
cells from tamoxifen-injected CY and CFY mice and compared
them to GFP+ cells from MIP-GFP mice as a positive control
for b cells (Figure 7A). CFY GFP+ ductal cells showed a modest
increase in expression of numerous b cell specific genes,
consistent with a small subset of ductal cells undergoing b cell
conversion. In agreement with the increase in Ngn3 stability in
Fbw7-deleted cells, CFY GFP+ ductal cells also showed an
increase in the expression of reported Ngn3 target genes
(Chga, Insm1,Dll3, Syp,Chn1,HeyL, Atp2a3, and Pcsk2; Swales
et al., 2012) (Figure 7B). qPCR analysis confirmed increased
mRNA expression of the b cell marker genes Ins2, Gck, Pdx1,
and Nkx6.1 in CFY GFP+ ductal cells compared with CY GFP+
cells (Figure 7C).
As well as showing gene expression characteristics of islet b
cells, insulin-positive cells in the ducts of CFY mice costained
with the functional b cell markers c-PPT, Glut2, MafA1, Nkx6.1,
Pax6, PC1/3, Pdx1, Urocortin 3 (Ucn3), and Isl1, showing com-
parable staining to islet b cells (Figures 7D, 7E, and S5). Insu-
lin-positiveCFY ductal cells were negative for the ductal markers
Sox9 and DBA, while other CFY ductal cells retained expression
of these markers (Figures 7E and S5).
An important hallmark of b cell function is the ability to
release insulin after glucose stimulation. To test this, weGSK3b phosphorylation site in mouse Ngn3. S, serine; A, alanine.
ight: Fbw7a-Flag IP from HEK293T cells co-transfected with Ngn3–HA or the
re measured after cycloheximide treatment in cells transfected with different
rcentage of initial protein levels.
; n = 3 independent experiments. See also Figure S4 and Table S1.
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Figure 5. Conditional Overexpression of Ngn3-AA in the Adult Pancreatic Ducts Is Sufficient to Induce b Cell Neogenesis
(A) Schematic representation of the Pdx1-Cre; R26-LSL-Ngn3-AA model.
(B) R26-LSL-Ngn3-AA recombination PCR performed in genomic DNA from tail (T), liver (L) and pancreas (P).
(C) Western blot analysis for Ngn3 in R26-LSL-Ngn3-AA or Pdx1-Cre; R26-LSL-Ngn3-AA mouse pancreas and liver.
(D) qPCR analysis of Ngn3 and Ins2 in R26-LSL-Ngn3-AA or Pdx1-Cre; R26-LSL-Ngn3-AA pancreas. n = 3 mice per genotype. Error bars indicate SEM.
(E) Insulin staining in R26-LSL-Ngn3-AA or Pdx1-Cre; R26-LSL-Ngn3-AA mouse pancreas. Scale bar, 300 mm.
(F) Quantification of insulin-positive (ins+) area in R26-LSL-Ngn3-AA (n = 14 sections; 578 islets/3 mice) or Pdx1-Cre; R26-LSL-Ngn3-AA (n = 20 sections;
900 islets/4 mice). Dots represent percentage of ins+ cells for each section. Error bars represent mean ± SEM.
(G) Scheme of the CK19-CreERT; R26-LSL-Ngn3-AA model.
(H) Schematic diagram of the CK19-CreERT; R26-LSL-Ngn3-AA pancreas before and after tamoxifen injection.
(I) GFP immunoperoxidase staining in R26-LSL-Ngn3-AA or CK19-CreERT; R26-LSL-Ngn3-AA pancreas after tamoxifen injection. Dashed square indicates the
area magnified.
(J) Representative picture showing insulin-positive cells in the pancreatic duct of tamoxifen-injected CK19-CreERT; R26-LSL-Ngn3-AA mice.
In (I) and (J), n > 5 mice per genotype (representative picture shown).
(K) Quantification of insulin-positive ductal cells in tamoxifen-injected R26-LSL-Ngn3-AA (n = 5 mice/3,462 cells) and CK19-CreERT; R26-LSL-Ngn3-AA animals
(n = 8 mice/5,965 cells). Data are represented as mean + SEM.
See also Table S1.
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Fbw7 Loss Reprograms Ductal Cells to b Cellssubjected GFP+ cells sorted from CY and CFYmouse pancreas
to in vitro glucose challenge (Figures 7F and 7G). WhileCYGFP+
cells did not respond to glucose, CFYGFP+ cells showed a sub-
stantial release of insulin (Figure 7G). Each CFY well of 30,000
cells contained approximately 300 converted b cells (based on
a 1% conversion frequency), which secreted 214 pg (1.07 ng/
ml) of insulin, i.e., 0.71 pg per cell. By comparison, 5,000 islet b
cells sorted from a MIP-GFP pancreas responded to glucose
by releasing 3,378 pg (16.89 ng/ml) of insulin, i.e., 0.67 pg per
cell (Figure 7H). Based on this result, the response to glucose
challenge in the converted cells is comparable to that of islet b
cells (Figure 7I). Thus, the b cells converted after Fbw7 loss in
the adult pancreatic ducts show both the characteristic marker
expression and functionality of mature b cells.
DISCUSSION
Ectopic expression of combinations of transcription factors can
induce changes of cellular fate in adult pancreatic tissue (Zhou
et al., 2008); however, examples of reprogramming in vivo by
loss of a single molecule are rare. In this study we show that
Fbw7 maintains adult ductal cell fate, as Fbw7 inactivation re-
sults in transdifferentiation of ductal cells into a and d cells
and, predominantly, b cells. The newly formed b cells resemble
islet b cells with regard to cellular morphology, marker gene
expression, and insulin secretion in response to glucose chal-
lenge. Our findings indicate an unexpected plasticity of ductal
cells, in which loss of a single gene (Fbw7) renders the duct cells
multipotent, able to remain exocrine or transdifferentiate into
endocrine a, d, or b cell types.
Fbw7 Function in the Adult Pancreas
Fbw7 is a key regulator of stem cell function, as Fbw7 inactiva-
tion results in increased proliferation and impaired differentiation
of hematopoietic, liver, intestinal, and neural progenitor cells
(Hoeck et al., 2010; Iriuchishima et al., 2011; Matsumoto et al.,
2011; Onoyama et al., 2011; Sancho et al., 2010, 2013). The
potent tumor suppressor function of Fbw7 is likely to be a direct
consequence of deregulated stem cell proliferation and differen-
tiation (Wang et al., 2012). However, the role of Fbw7 in the
pancreatic ducts is distinct from Fbw7 function in other organ
systems. Ductal to endocrine cell transdifferentiation after
Fbw7 loss occurs in the absence of proliferation, suggesting
that the subset of cells that respond to Fbw7 deletion in this
way does not behave as adult stem cells in other organ systems,
requiring cell division before differentiation. Rather, Fbw7 seems
to function in the adult pancreas to constantly maintain cell fate
in a subset of ductal cells.
Fbw7 Loss Converts Adult Ductal Cells into Functional
b Cells
We found that the expression and activity of Fbw7 in the adult
pancreas is enriched in the ductal compartment. Adult pancre-
atic ducts have been suggested to harbor b cell progenitors,
which are reactivated after challenge (Bonner-Weir et al.,
2008). Pancreatic duct ligation (PDL), combined with lineage
tracing of the ductal epithelium, demonstrated that a quarter
of new b cells formed in response to injury were derived from
ductal cells (Inada et al., 2008). In contrast, alloxan treatmentCwas recently shown to induce transdifferentiation of acinar
cells into b cells (Baeyens et al., 2014). We found that Fbw7
expression was quickly and dramatically downregulated
24 hr after PDL, but alloxan treatment induced no change in
Fbw7 expression (Figures S6A and S6B). These data suggest
that Fbw7 transcriptional downregulation may contribute to
duct-derived b cell neogenesis in response to pancreatic injury
(Figure S6C).
Although it is conceivable that b cells produced elsewhere
could migrate to the ducts, the location of induced b cells
embedded within the ducts suggests that they originated in
this compartment. Several lines of evidence support this
interpretation: first, ‘‘transition’’ cells coexpressing ductal cell
(CK19) and b cell (ins) markers are observed after Fbw7 loss;
second, genetic models in which recombination is inefficient in
ducts (such as RFY mice injected intrapancreatically with OH-
tamoxifen) do not induce b cell neogenesis; and third, duct-spe-
cific Fbw7 loss combined with lineage tracing (our CFY model)
induces the occurrence of ductal YFP-labeled insulin-positive
cells.
Insulin-positive cells are also observed in ducts of normal
unchallenged mice, albeit rarely (Teta et al., 2005), a finding we
confirmed in this study. It is not knownwhether this spontaneous
transdifferentiation process is similar to the reprogramming
induced by Fbw7 inactivation. However, bihormonal insulin/
glucagon double-positive cells—presumptive a and b cell
precursors during embryonic pancreas development (De Krijger
et al., 1992) that we also observed in Fbw7 deleted ducts—have
not been described in unchallenged adult WT pancreas. Simi-
larly, CK19/insulin transdifferentiation intermediates have not
been reported in normal mice. Thus, b cell reprogramming
induced by Fbw7 inactivation appears to be a distinct process
from the spontaneous appearance of insulin-positive cells in
WT pancreatic ducts and may represent a reawakening of a
multipotent state.
A frequent stumbling block in previous models inducing cell
reprogramming has been the functionality of the newly formed
b cells. It is important to note that Fbw7-mutant induced b cells
secrete comparable amounts of insulin after glucose challenge
as bona fide b cells isolated from MIP-GFP mice. Therefore,
Fbw7 loss appears to trigger the conversion of adult pancreatic
ductal cells into apparently functional b cells.
The Fbw7-Ngn3 Axis as aMechanism Regulating Adult b
Cell Neogenesis
The activity of Fbw7 toward different substrates is tissue spe-
cific, and our results show that, in the pancreas, c-Jun, Notch,
and Ngn3 levels are increased after Fbw7 deletion. While
c-Jun has no reported function in pancreatic cell fate decisions,
the Notch signaling pathway is thought to inhibit pancreatic
endocrine development (Apelqvist et al., 1999; Fujikura et al.,
2006; Jensen et al., 2000; Oka et al., 1995). In contrast, we find
that endocrine differentiation in the ducts after Fbw7 deletion is
accompanied by an increase in NICD1 levels. This could imply
that Notch has different roles in embryonic and adult pancreatic
b cell differentiation, but it is also possible that increased Notch
signaling is not required for b cell neogenesis after Fbw7 loss,
and b cell neogenesis is induced despite an overall increase in
Notch levels.ell Stem Cell 15, 139–153, August 7, 2014 ª2014 The Authors 147
(legend on next page)
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Cell Stem Cell
Fbw7 Loss Reprograms Ductal Cells to b CellsThe stabilization of Ngn3 after Fbw7 loss is consistent with a
strong proendocrine signal. Ngn3 has been previously reported
to be required for PDL- and Pax4 overexpression-induced b
cell neogenesis (Al-Hasani et al., 2013; Xu et al., 2008), and our
data show that Ngn3 stabilization in the ducts is sufficient to
induce b cell neogenesis (Figure 5). Despite its essential role in
endocrine differentiation, and the reported Ngn3 instability at
the protein level, the regulatory mechanisms that control the
abundance of Ngn3 are not fully understood. In this study, we
show that Ngn3 is a substrate for SCF(Fbw7). Ngn3 behaves
as a canonical Fbw7 substrate, containing a GSK3 consensus
phosphorylation site that, when mutated, increases the stability
of the protein. Our data indicate that Ngn3 stabilization after
Fbw7 loss contributes to a transdifferentiation program, inducing
ductal cells to differentiate into b cells. Induction of adult b cell
neogenesis is desirable for diabetes treatment, and modulation
of the Fbw7-Ngn3 axis could potentially be exploited as a
therapeutic approach toward generation of new b cells for cell
replacement therapies.
EXPERIMENTAL PROCEDURES
Mouse Lines
The Pdx1-Cre (Hingorani et al., 2003), R26-LSL-YFP (Srinivas et al., 2001),
CK19-CreERT (Means et al., 2008), R26-CreERT (Ventura et al., 2007), MIP-
GFP (Hara et al., 2003), and Fbw7f/f (Jandke et al., 2011) mouse lines have
been previously described. The R26-LSL-Ngn3-AA mouse was generated
using mouse Ngn3-AA complementary DNA (cDNA) to create a conditional
Rosa26-Ngn3-AA-IRES-eGFP-pA+ targeting vector as described elsewhere
(Nyabi et al., 2009), followed by selection of embryonic stem cell clones
targeted with linearized vector and generation of chimeric Swiss diploid
embryos. All animal experiments were approved by the CRUK London
Research Institute Animal Ethics Committee and conformed with UK Home
Office regulations under the Animals (Scientific Procedures) Act 1986 including
Amendment Regulations 2012.
Cell Lines and Plasmids
HCT116-Fbw7wt and HCT116-Fbw7D cells, and Fbw7a–Flag and Fbw7b–Flag
constructs, have been described elsewhere (Grim et al., 2008). Full-length
Ngn3cDNA frommouseembryonic pancreaswasobtainedbyPCRandcloned
intopcDNA3 togenerate thepcDNA3-Ngn3plasmid.MutationofNgn3Ser183/
Ser187 to alanine was achieved by conventional PCR site-directed mutagen-
esis. p-RS-sh-control and p-RS-sh-Fbw7 constructs were generated by clon-
ing short hairpin-containing oligos into the pRS vector (Addgene).
Genetic Labeling Experiments
For all experiments, adult (6–9 weeks except where indicated) age- and strain-
matched animals were used. Mice were either injected intraperitoneally withFigure 6. Fbw7 Deletion in the Adult Pancreatic Ducts Induces Dir
Cell Division
(A) Scheme of the CY and CFY mouse model genotypes.
(B) Schematic diagram of CY pancreas before and after tamoxifen injection.
(C) PCR analysis of the Fbw7 andR26 loci on genomic DNA isolated fromGFP-sor
Fbw7f unrecombined allele; D, Fbw7 recombined allele; R26-LSL, R26 unrecom
(D) qPCR analysis of Fbw7mRNA in GFP+ (duct) and GFP (endocrine and acinar
each) and GFP+ (b) cells from MIP-GFP mice (n = 3 pooled pancreas). n = 3 inde
(E and F) Quantification of number of ducts (E) or islets (F) per square millimeter i
scale bar, 20 mm; n = 3 mice/genotype. ns, not significant.
(G) Quantification of the percentage of total ductal cells that are insulin positive i
12,220 cells). Representative example in adjacent picture; scale bar, 20 mm.
(H–J) Triple IF for GFP, insulin (ins), and BrdU in tamoxifen-injected CY (H) or CF
sentative picture shown). Nuclei were counterstained with DAPI. White dashed s
See also Figure S4 and Table S1.
C100 mg/g body weight of tamoxifen dissolved in peanut oil (at least three
mice per genotype) or intrapancreatically injected with 20 ml–50 mM 4-OH-
tamoxifen (two mice per genotype) as indicated. Analyses were performed
5/13 days (short term) or 60/82 days (long term) postinjection. Where indi-
cated, BrdU (0.8 mg/ml) was given in drinking water 1 day before the first
tamoxifen injection and kept until the end of the experiment. The pancreas
was excised, processed, and stained as described in the Supplemental Exper-
imental Procedures.
IF and Immunohistochemistry Staining
Rhodamine-DBA (Sigma) was used to detect ductal cells by confocal micro-
scopy. IF and immunohistochemistry staining was performed as described
elsewhere (Sancho et al., 2010). Antibodies are listed in the Supplemental
Experimental Procedures. Quantification of the insulin-positive area in Ngn3
conditional transgenic mouse pancreas was performed on NanoZoomer
2.0-HT (HAMAMATSU) scanned slides using AdobePS-CS5.
Western Blot Analysis
Pancreas lysates were homogenized in RIPA lysis buffer supplemented
with protease inhibitor (Sigma). 293T cells were lysed in NP-40 lysis buffer. Im-
munoblots were carried out as described elsewhere (Nateri et al., 2005).
Antibodies are listed in the Supplemental Experimental Procedures.
Immunoprecipitations
Human embryonic kidney 293T (HEK293T) cells coexpressing HA-Ngn3 and
Fbw7-Flag were treated for 5 hr with proteasome inhibitor MG-132 (25 mM;
Calbiochem), lysed with 0.2% NP40 buffer, and incubated with anti-Flag or
anti-HA agarose beads (Sigma). For the endogenous Fbw7-Ngn3 interaction
assay, Ngn3 was immunoprecipitated from HCT116-Fbw7wt and HCT116-
Fbw7D cells transfected with Ngn3-AA. Endogenous Fbw7 in inputs and
immunoprecipitation (IP) samples was detected using anti-Fbw7 antibody
(Bethyl Laboratories).
Ubiquitination Assays
For in vivo ubiquitination assays, His-Ub was affinity purified with nickel-nitri-
lotriacetic acid (NTA)-agarose beads, as described elsewhere (Davies et al.,
2010). In vitro ubiquitination assays with Fbw7 and Fbw7a-DFbox-Flag immu-
noprecipitated complexes were performed as described elsewhere (Popov
et al., 2007).
Fluorescence-Activated Cell Sorting Analysis
Single pancreatic cell suspensions were obtained by 30 min digestion in
1.6 mg/ml collagenase type IV (Whorttington), followed by filtration on a
70 mm nylon mesh. Cells from six age-matched (6- to 8-week-old) mice per
genotype were sorted for GFP expression for each independent experiment.
DNA Isolation and Allele Recombination PCR
Genomic DNA from GFP+/GFP cells sorted from six tamoxifen-injected CFY
and CY mice was isolated by digestion in DirectPCR Lysis Reagent (Viagen).
PCR primers used to detect the efficiency of recombination of Fbw7 and
R26 alleles are given in the Supplemental Experimental Procedures.ect Conversion of Ductal Cells into b Cells with No Intermediate
tedCY andCFY cells 13 days post-tamoxifen injection. wt, Fbw7WTallele; flox,
bined allele; R26-D, R26 recombined allele.
) cells sorted from tamoxifen-injectedCFY andCYmice (n = 6 pooled pancreas
pendent experiments.
n at least seven fields per mouse (representative example in adjacent picture);
n tamoxifen-injected CY (n = 10 mice/10,070 cells) and CFY mice (n = 7 mice/
Y (I and J) mice (5 days post-tamoxifen injection; n > 5 mice/genotype; repre-
quare (I) represents the area magnified (J). Error bars in (D)–(G) indicate SEM.
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Figure 7. Converted b Cells Induced by Fbw7 Deletion Resemble Functional Mature b Cells
(A) Schematic diagram of the comparison strategy used for the mRNA expression profile.
(B) Heatmap representing expression of 15 b cell markers and 15Ngn3 target genes inGFP+ sorted cells from tamoxifen-injectedCY (n = 6),CFY (n = 6), andMIP-
GFP (n = 3) mice.
(C) qPCR analysis of Ins2,Gck,Pdx1, andNkx6.1 expression in GFP+ cells sorted fromCY andCFYmice (n = 6 pooled pancreas per genotype). n = 2 independent
experiments.
(D and E) Double IF of insulin (ins) together with different b cell markers or ductal markers (Sox9, Dolichos biflorus agglutinin) in ductal CFY b cells. Scale bars,
5 mm. n > 5 mice per genotype (representative picture shown).
(legend continued on next page)
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Cell Stem Cell
Fbw7 Loss Reprograms Ductal Cells to b CellsMicroarray Analysis and qPCR
RNAwas isolated from sortedGFP+ cells from tamoxifen-injectedCY andCFY
mice (six pooled pancreas per genotype) or MIP-GFP mice (three pooled
pancreas) using a RNeasy Micro Kit (QIAGEN). RNA microarray hybridizations
were performed by the Cancer Research UK Manchester Institute Microarray
Service using the GeneChip Mouse Gene 1.0 ST array (Affymetrix) after
genome amplification of the RNA.
For qPCR analysis of sorted cells, RNA was isolated as described for the
microarray, and cDNA amplification was performed using theQuantitect whole
transcriptome amplification kit (QIAGEN). For qPCR analysis in Pdx1-Cre;
Fbw7f/f mice, RNA was isolated using the RNeasy Mini Kit (QIAGEN), and
cDNA was generated using the Transcriptor First Strand cDNA Synthesis Kit
(Roche). Diluted cDNAs were used for qPCR SYBR-Green detection of target
genes, using primer sequences given in the Supplemental Experimental
Procedures.
Glucose Challenge In Vitro
Determination of insulin release after glucose challenge was performed as
described elsewhere (Banga et al., 2012), with minor modifications. Briefly,
30,000 GFP+ sorted CY or CFY cells (from six pooled pancreas per genotype)
or 5,000 GFP+ cells from MIP-GFP pancreas were plated per well in Dulbec-
co’s modified Eagle’s medium without serum/glucose/phenol red. Cells
were starved for 2 hr, the medium was changed, and 20 mM glucose was
added (final volume, 200 ml). Insulin concentration was determined in superna-
tants using the Mouse Insulin ELISA Kit (Crystal Chem).
Statistics
Statistical evaluation was performed using the Student’s unpaired t test. *p%
0.05, **p % 0.01, ***p % 0.001 were considered statistically significant. See
Table S1 for exact p values.
ACCESSION NUMBERS
The Gene Expression Omnibus accession number for the microarray data re-
ported in Figure 7B is GSE58969.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.stem.2014.06.019.
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